Long-term CNM-Au8 treatment demonstrated improvement of vision as measured by low contrast visual acuity (LCLA), an assessment of visual function in people living with multiple sclerosis (MS), through ...
East Hanover, NJ, February 14, 2022. A team of researchers published results of a study of the Symbol Digit Modalities Test (SDMT), a measure widely used for cognitive assessment in research and ...
Long-term CNM-Au8 treatment demonstrated significant and clinically meaningful improvement of vision as measured by low contrast letter acuity (LCLA), an assessment of visual function in people living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback